IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
RELIANT PHARMACEUTICALS, INC.,
Piaimirr Z
. v. C.A. No. 06-774-JIF
PAR PHARMACEUTICAL, INC., .
Defendant. I
. NOTICE OF SERVICE
PLEASE TAKE NOTICE that on September 21, 2007, copies of:
Ddendantis Objections and Responses to PlaintW’s First Set of Requests
for Admissions; and
D¢y’endant’s Objections and Responses to PlaintW’s Second Set of
Requests for the Production of Documents and Things;
were served upon the following counsel of record in the manner indicated:
By E-mail By Hand Deliveyy and E-mail
Jack B. Blumenfeld [[email protected]] John Desmarais [idesmarais@l
Moms Nici-tors Ansar & TUNNELL [gt1attmann@1;ir1dand.cem]
1201 North Market Street Christine Willgoos [[email protected]]
P.0. Box 1347 KIRKLAND & ELLIS LLP
Wilmington, DE 19899 Citigroup Center
(302) 658-9200 153 E. 53rd Street
New York, NY 10022
Steven C. Chemy [[email protected]] (212) 446-4800
LATHAM & WATKINS LLP ·
885 Third Avenue, Suite 1000
New York, NY 10022-4834
(212) 906-1200
nBoz;604x9sv.1 0660394001
Case 1 :O6—cv—OO774-JJF Document 98 Filed O9/21/2007 Page 2 of 2
Additionally, the undersigned hereby certifies that on September 21, 2007, this Notice of
Service was electronically tiled with the Clerk ofthe Court using CM/ECF and served upon the
above-listed counsel of record by e-mail.
_ YOUNG CoNAwAY STARGATT & TAYLOR LLP
/s/ Karen L. Wascalé ’
September 21, 2007 ‘ .
Josy W. Ingersoll (No. 1088) [[email protected]]
Karen L. Pascale (No. 2903) [[email protected]]
Karen E. Keller (No. 4489) [[email protected]]
The Brandywine Building
1000 West St., 17th Floor
P.O. Box 391
Wilmington, Delaware 19899-0391
V Telephone: 302-571-6600
Facsimile: 302-571-1253
FRo1v1MER LAWRENCE & HAUG LLP
Edgar H. Hang
James K. Stronski
John G. Taylor
745 Fifth Avenue
New York, New York 10151
Telephone: (212) 588-0800
Facsimile: (212) 588-0500
STILLMAN, FRIEDMAN & SHECHTMAN, P.C.
John B. Harris
Mary Margulis—Ohnuma
425 Park Avenue
New York, NY 10022
Telephone: (212) 223-0200
Attorneys for De]%na’am§ Par Pharmaceutical, Inc.
DB02;6049s71.1 2 0660391001